Drug Type Prophylactic vaccine |
Synonyms- |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization ProBioGen AGDiosynvax Ltd.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hemorrhagic Fever, Ebola | Preclinical | DE | 27 Mar 2024 | |
Hemorrhagic Fever, Ebola | Preclinical | NZ | Diosynvax Ltd.Startup | 27 Mar 2024 |
Lassa Fever | Preclinical | NZ | Diosynvax Ltd.Startup | 27 Mar 2024 |
Lassa Fever | Preclinical | DE | 27 Mar 2024 | |
Marburg Virus Disease | Preclinical | DE | 27 Mar 2024 | |
Marburg Virus Disease | Preclinical | NZ | Diosynvax Ltd.Startup | 27 Mar 2024 |